211 related articles for article (PubMed ID: 21935641)
1. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
2. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet's disease.
Kikuchi H; Takayama M; Hirohata S
J Neurol Sci; 2014 Feb; 337(1-2):80-5. PubMed ID: 24289890
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
[TBL] [Abstract][Full Text] [Related]
5. Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.
Ishido M; Horita N; Takeuchi M; Shibuya E; Yamane T; Kawagoe T; Ishido T; Minegishi K; Yoshimi R; Kirino Y; Hirohata S; Ishigatsubo Y; Takeno M; Kaneko T; Mizuki N
Sci Rep; 2017 Aug; 7(1):10196. PubMed ID: 28860590
[TBL] [Abstract][Full Text] [Related]
6. [A case of chronic progressive neuro-Behçet disease with extensive cerebral atrophy and elevated CSF IL-6 activity treated with infliximab].
Hamada K; Takei R; Sakiyama Y; Moriyama H; Hashiguchi A; Takashima H
Rinsho Shinkeigaku; 2018 Jan; 58(1):30-34. PubMed ID: 29269695
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the clinical characteristics of 25 cases with parenchymal neuro-Behcet's disease].
Li Y; Shi Q; Lin Y; Liu MY; Liu JQ
Zhonghua Nei Ke Za Zhi; 2023 Jul; 62(7):808-813. PubMed ID: 37394850
[No Abstract] [Full Text] [Related]
8. Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.
Belghith M; Maghrebi O; Ben Laamari R; Hanachi M; Hrir S; Saied Z; Belal S; Driss A; Ben Sassi S; Boussoffara T; Barbouche MR
Cytokine; 2024 Jul; 179():156617. PubMed ID: 38631183
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro-Behçet's disease.
Park KS; Ko HJ; Yoon CH; Park SH; Cho CS; Kim HY; Choe BY; Kim WU
Clin Exp Rheumatol; 2004; 22(5):561-7. PubMed ID: 15485008
[TBL] [Abstract][Full Text] [Related]
10. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
11. The Cerebrospinal Fluid Presentations of Neuro-Bechet Disease, a Way to Know the Etiopathogenesis and Improve Armamentarium.
Banerjee S; Hamzoui K; Safari A; Borhani-Haghighi A
Iran J Immunol; 2021 Sep; 18(3):170-178. PubMed ID: 34596581
[TBL] [Abstract][Full Text] [Related]
12. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
14. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
[TBL] [Abstract][Full Text] [Related]
15. The clinical and radiological features and prevalence of Neuro-Behçet's Disease: A retrospective cohort multicenter study in Saudi Arabia.
Makkawi S; Aljafari D; Alsharif R; Maaddawi H; Alwagdani A; Aljumah T; Alghweinem Z; Alshehri S; Khojah O; Halawani A; Ahmed Adas R; Abulaban A; Al Malik Y
Mult Scler Relat Disord; 2024 May; 85():105558. PubMed ID: 38569381
[TBL] [Abstract][Full Text] [Related]
16. A pediatric patient with neuro-Behçet's disease.
Hatachi S; Nakazawa T; Morinobu A; Kasagi S; Kogata Y; Kageyama G; Kawano S; Koshiba M; Kumagai S
Mod Rheumatol; 2006; 16(5):321-3. PubMed ID: 17039316
[TBL] [Abstract][Full Text] [Related]
17. Significance of immunoglobulins synthesis with central nervous system involvement in Neuro-Behçet's disease.
Zhan H; Cheng L; Liu Y; Xu H; Feng X; Liu Y; Li H; Li Z; Wang S; Jin H; Zheng W; Hao H; Li Y
Clin Chim Acta; 2024 Jun; 559():119681. PubMed ID: 38643816
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
Farahangiz S; Sarhadi S; Safari A; Borhani-Haghighi A
Int J Rheum Dis; 2012 Dec; 15(6):e142-9. PubMed ID: 23253242
[TBL] [Abstract][Full Text] [Related]
19. Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
Akman-Demir G; Mutlu M; Kiyat-Atamer A; Shugaiv E; Kurtuncu M; Tugal-Tutkun I; Tuzun E; Eraksoy M; Bahar S
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S80-4. PubMed ID: 26486298
[TBL] [Abstract][Full Text] [Related]
20. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment.
Borhani-Haghighi A; Kardeh B; Banerjee S; Yadollahikhales G; Safari A; Sahraian MA; Shapiro L
Mult Scler Relat Disord; 2020 Apr; 39():101906. PubMed ID: 31887565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
